China Kidney Disease Network (CK-NET) 2016 Annual Data Report.
作者信息
Zhang Luxia, Zhao Ming-Hui, Zuo Li, Wang Yue, Yu Feng, Zhang Hong, Wang Haibo
机构信息
Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
National Institute of Health Data Science at Peking University, Beijing, China.
出版信息
Kidney Int Suppl (2011). 2020 Dec;10(2):e97-e185. doi: 10.1016/j.kisu.2020.09.001. Epub 2020 Dec 1.
Abstract
摘要
相似文献
1
China Kidney Disease Network (CK-NET) 2016 Annual Data Report.中国肾脏病网（CK-NET）2016年度数据报告。
Kidney Int Suppl (2011). 2020 Dec;10(2):e97-e185. doi: 10.1016/j.kisu.2020.09.001. Epub 2020 Dec 1.
2
Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET).2015 年中国肾脏病网络（CK-NET）年度数据报告执行摘要。
Kidney Int. 2019 Mar;95(3):501-505. doi: 10.1016/j.kint.2018.11.011.
3
Corrigendum to "Zhang L, Zhao M-H, Zuo L, et al., on behalf of CK-NET Group. China Kidney Disease Network (CK-NET) 2015 Annual Data Report." 2019;9:e1-e81.《张L、赵M-H、左L等代表CK-NET集团。中国肾脏疾病网络（CK-NET）2015年度数据报告》勘误 2019年；9：e1-e81。
Kidney Int Suppl (2011). 2020 Mar;10(1):e95. doi: 10.1016/j.kisu.2019.05.001. Epub 2020 Feb 19.
4
Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report.中国肾脏病网络（CK-NET）2016 年度数据报告摘要。
Kidney Int. 2020 Dec;98(6):1419-1423. doi: 10.1016/j.kint.2020.09.003.
5
China Kidney Disease Network (CK-NET) 2015 Annual Data Report.中国肾脏病网（CK-NET）2015年度数据报告。
Kidney Int Suppl (2011). 2019 Mar;9(1):e1-e81. doi: 10.1016/j.kisu.2018.11.001. Epub 2019 Feb 20.
6
China Kidney Disease Network (CK-NET) 2014 Annual Data Report.中国肾脏病网络（CK-NET）2014年度数据报告。
Am J Kidney Dis. 2017 Jun;69(6S2):A4. doi: 10.1053/j.ajkd.2016.06.011.
7
Wang F, Yang C, Long J, et al. Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET). Kidney Int. 2019;95:501-505.王F、杨C、龙J等。中国肾脏病网络（CK-NET）2015年度数据报告执行摘要。《国际肾脏杂志》。2019年；95：501 - 505。
Kidney Int. 2019 Aug;96(2):525. doi: 10.1016/j.kint.2019.05.004.
8
Using electronic health record data to establish a chronic kidney disease surveillance system in China: protocol for the China Kidney Disease Network (CK-NET)-Yinzhou Study.利用电子健康记录数据在中国建立慢性肾脏病监测系统：中国肾脏病网络（CK-NET）-鄞州研究方案。
BMJ Open. 2019 Aug 28;9(8):e030102. doi: 10.1136/bmjopen-2019-030102.
9
The China Kidney Disease Network (CK-NET): "Big Data-Big Dreams".中国肾脏病网（CK-NET）：“大数据-大梦想”
Am J Kidney Dis. 2017 Jun;69(6):713-716. doi: 10.1053/j.ajkd.2017.04.008.
10
[Effects of different long-term fertilization patterns on net carbon sink effect and economic benefits in double cropping rice paddy ecosystem in southern China].[不同长期施肥模式对中国南方双季稻田生态系统净碳汇效应及经济效益的影响]
Ying Yong Sheng Tai Xue Bao. 2022 Sep;33(9):2450-2456. doi: 10.13287/j.1001-9332.202209.011.
引用本文的文献
1
Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors.用于终末期肾病患者的PBPK群体模型的开发，以了解OATP1B、BCRP、P-糖蛋白和CYP3A4介导的药物处置及个体影响因素。
Pharmaceutics. 2025 Aug 20;17(8):1078. doi: 10.3390/pharmaceutics17081078.
2
Predictive value of ferritin heavy chains in the development of coronary artery calcification in patients on maintenance hemodialysis: a prospective cohort study.铁蛋白重链对维持性血液透析患者冠状动脉钙化发展的预测价值：一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2025 Jul 30;16:1503940. doi: 10.3389/fendo.2025.1503940. eCollection 2025.
3
The mediating effect of alexithymia in the symptom burden and depression in patients with maintenance hemodialysis.述情障碍在维持性血液透析患者症状负担与抑郁之间的中介作用。
Front Psychol. 2025 Jul 8;16:1570190. doi: 10.3389/fpsyg.2025.1570190. eCollection 2025.
4
Research on TCM Comprehensive Treatment of DKD Based on Pathophysiological Mechanism.基于病理生理机制的糖尿病肾病中医综合治疗研究
Diabetes Metab Syndr Obes. 2025 Jul 16;18:2369-2384. doi: 10.2147/DMSO.S523094. eCollection 2025.
5
Association between physiological serum total bilirubin concentrations and the progression of diabetic nephropathy.生理血清总胆红素浓度与糖尿病肾病进展之间的关联。
Front Endocrinol (Lausanne). 2025 May 29;16:1588568. doi: 10.3389/fendo.2025.1588568. eCollection 2025.
6
Explore the effect of HIF-PHI on blood pressure variation rate and anemia efficacy in maintenance hemodialysis patients.探讨缺氧诱导因子脯氨酰羟化酶抑制剂（HIF-PHI）对维持性血液透析患者血压变异性及贫血疗效的影响。
BMC Nephrol. 2025 May 29;26(1):267. doi: 10.1186/s12882-024-03928-w.
7
Mediating effect of work engagement and career success on work-family support and turnover intention of hemodialysis nurses in China: a cross-section study.工作投入和职业成功对中国血液透析护士工作-家庭支持与离职意愿的中介作用：一项横断面研究
BMC Nurs. 2025 May 26;24(1):587. doi: 10.1186/s12912-025-03223-5.
8
Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast China.肾脏疾病谱的变化：来自中国东南部的一项为期14年的单中心回顾性肾活检研究
PeerJ. 2025 Apr 14;13:e19302. doi: 10.7717/peerj.19302. eCollection 2025.
9
Cost-effectiveness of population-based screening for chronic kidney disease among the general population and adults with diabetes in China: a modelling study.中国普通人群和糖尿病成年人中基于人群的慢性肾脏病筛查的成本效益：一项建模研究。
Lancet Reg Health West Pac. 2025 Feb 17;56:101493. doi: 10.1016/j.lanwpc.2025.101493. eCollection 2025 Mar.
10
Organoids as Sophisticated Tools for Renal Cancer Research: Extensive Applications and Promising Prospects.类器官作为肾癌研究的精密工具：广泛应用与广阔前景
Cell Mol Bioeng. 2024 Oct 15;17(6):527-548. doi: 10.1007/s12195-024-00825-y. eCollection 2024 Dec.
本文引用的文献
1
Pathophysiology of AKI to CKD progression.AKI 向 CKD 进展的病理生理学。
Semin Nephrol. 2020 Mar;40(2):206-215. doi: 10.1016/j.semnephrol.2020.01.011.
2
Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis.制定血液透析和腹膜透析最低及最佳安全与质量标准框架。
Kidney Int Suppl (2011). 2020 Mar;10(1):e55-e62. doi: 10.1016/j.kisu.2019.11.009. Epub 2020 Feb 19.
3
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担，1990-2017 年：2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
4
US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2019年年报：美国肾脏疾病流行病学
Am J Kidney Dis. 2020 Jan;75(1 Suppl 1):A6-A7. doi: 10.1053/j.ajkd.2019.09.003. Epub 2019 Nov 5.
5
Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey.全球各国和地区终末期肾病护理状况：国际横断面调查。
BMJ. 2019 Oct 31;367:l5873. doi: 10.1136/bmj.l5873.
6
Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.慢性肾脏病与冠状动脉疾病：美国心脏病学会心血管介入治疗学会最新进展综述。
J Am Coll Cardiol. 2019 Oct 8;74(14):1823-1838. doi: 10.1016/j.jacc.2019.08.1017.
7
Big data in nephrology: Are we ready for the change?肾脏病学中的大数据：我们是否已准备好迎接变革？
Nephrology (Carlton). 2019 Nov;24(11):1097-1102. doi: 10.1111/nep.13636. Epub 2019 Aug 5.
8
Chronic kidney disease, heart failure and neprilysin inhibition.慢性肾脏病、心力衰竭与 Neprilysin 抑制。
Nephrol Dial Transplant. 2020 Apr 1;35(4):558-564. doi: 10.1093/ndt/gfz058.
9
China Kidney Disease Network (CK-NET) 2015 Annual Data Report.中国肾脏病网（CK-NET）2015年度数据报告。
Kidney Int Suppl (2011). 2019 Mar;9(1):e1-e81. doi: 10.1016/j.kisu.2018.11.001. Epub 2019 Feb 20.
10
Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET).2015 年中国肾脏病网络（CK-NET）年度数据报告执行摘要。
Kidney Int. 2019 Mar;95(3):501-505. doi: 10.1016/j.kint.2018.11.011.
Zotero 插件